Summary
The binding of 8 β-adrenergic blocking drugs to human serum albumin, to α1-acid glycoprotein and to serum from normal volunteers and from patients with rheumatoid arthritis was studied. Protein binding was determined in vitro using equilibrium dialysis of labelled drug at 25° C. Oxprenolol and propranolol were highly bound to serum, alprenolol, pindolol and timolol to a lesser degree, and atenolol, metoprolol and sotalol were negligibly bound. For the five compounds which were appreciably bound, the mean binding was significantly higher in serum from patients with rheumatoid arthritis than in serum from normal volunteers. For those drugs, binding to α1-acid glycoprotein was higher than to human serum albumin, and binding to a mixture of both proteins approached that to serum from healthy volunteers. For each of these drugs there was a strong correlation between the serum α1-glycoprotein concentration and the percentage binding.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Johnsson G, Regardh G (1976) Clinical pharmacokinetics of β-adrenoceptor blocking drugs. Clin Pharmacokinet 1: 233–263
Piafsky KM, Borgå O (1977) Plasma protein binding of basic drugs. II. Importance of α1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther 22: 545–549
Piafsky KM, Borgå O, Odar-Cederlöf I, Johansson C, Sjöqvist F (1978) Increased plasma protein binding of propranolol and chlorpromazine mediated by disease induced elevations of plasma α1-acid glycoprotein. N Engl J Med 299: 1435–1439
Belpaire FM, Bogaert MG, Rosseneu M, Teirlynck O (1981) Binding of β-adrenoceptor antagonists to human serum albumin, α1-acid glycoprotein and human serum. Br J Clin Pharmacol 11: 125P-126P
Johansson KA, Appelgren C, Borg KO, Elofsson R (1974) Binding of two adrenergic beta-receptor antagonists, alprenolol and H93/26 to human serum proteins. Acta Pharm Suec 11: 333–346
Riess W, Brechbühler S, Theobald W (1976) Pharmacokinetic characteristics of beta-receptor antagonists in man-similarities and differences of clinical relevance. Austr N Z J Med 6 (Suppl. 3): 4–13
Henry JA, Mitchell SN (1981) Effect of pH on human plasma protein binding of a series of β-adrenoceptor antagonists. Br J Clin Pharmacol 11: 119P-120P
Antilla M, Arstilla M, Pfeffer M, Tikkanen R, Vallinkoski V, Sundquist H (1976) Human pharmacokinetics of sotalol. Acta Pharmacol Toxicol 39: 118–128
Giudicelli JF, Tillement JP, Boissier JR (1973) Activité β-adrénolytique comparée in vitro et in vivo et fixation protéique. J Pharmacol (Paris) 4: 129–136
Glasson S, Zini R, d'Athis PH, Tillement JP, Boissier JR (1980) The distribution of bound propranolol between the different human serum proteins. Mol Pharmacol 17: 187–191
Routledge PA, Stargel NW, Wagner GS, Shand DG (1980) Alpha-1 acid glycoprotein and the disposition of lidocaine in health and myocardial infarction. Clin Pharmacol Ther 27: 291
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Belpaire, F.M., Bogaert, M.G. & Rosseneu, M. Binding ofβ-adrenoceptor blocking drugs to human serum albumin, to α1-acid glycoprotein and to human serum. Eur J Clin Pharmacol 22, 253–256 (1982). https://doi.org/10.1007/BF00545224
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00545224